Shreya Somasundaran

Shreya Somasundaran

Auto-generated profile, based on publicly available information

Shreya Somasundaran

Centre for Ophthalmology and Visual Science/Lions Eye Institute University of Western Australia Nedlands Western Australia Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
SSShreya Somasundaran
Shreya Somasundaran
ICIan J. Constable
Ian J. Constable
CMCarla B. Mellough
Carla B. Mellough
Livia S CarvalhoLivia S Carvalho
Livia S Carvalho
Age‐related macular degeneration (AMD) is a progressive degenerative disease that is the leading cause of vision loss in the elderly population. Degeneration/dysregulation of the retinal pigment epithelium (RPE), a supportive monolayer of cells underlying the photoreceptors, is commonly seen in patients with AMD. While treatment exists for the neovascular/wet form of AMD, there is currently no cure for the non‐exudative/dry form of AMD, making it imperative to understand the pathogenesis of this disease. Although our understanding of the aetiology of AMD has increased over the years, the underlying disease mechanism has not yet been identified, mainly due to the multifactorial nature of this disease. Herein, we review some of the commonly proposed degeneration pathways of RPE cells and their role in the pathogenesis of AMD; including activation of the complement cascade, oxidative stress‐induced cell death mechanisms, dysfunctional mitochondria and the role of crystallins in AMD disease progression.